Início › Câncer de Mama › Carolina do Sul

Ensaios clínicos de Câncer de Mama em Carolina do Sul

23 estudos para Câncer de Mama estão buscando participantes em locais em Carolina do Sul.

Cidades em Carolina do Sul

Texto oficial do estudo (Inglês)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Bon Secours St Francis Cancer Center, Greenville

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
e mais 12

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

CBD for Breast Cancer Primary Tumors

Medical University of South Carolina, Charleston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06148038

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
St Francis Cancer Center ( Site 0093), Greenville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06966700

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

St. Joseph's Candler Bluffton Campus, Bluffton
SC Cancer Specialists - Hilton Head at St. Joseph's/Candler, Hilton Head Island
Levine Cancer Institute, Rock Hill

RecrutandoFase 3

Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06377852

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Medical University of South Carolina, Charleston

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Hollings Cancer Center, Charleston

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06492616

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Spartanburg Regional Healthcare System, Spartanburg

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Bon Secours - St. Francis Hospital, Greenville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
e mais 14

RecrutandoFase 3

Idades de 18 a 60 · Mulheres · Atualizado em 2 de set. de 2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

St Francis Cancer Center, Greenville

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

Beaufort Memorial Hospital, Beaufort
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
e mais 10

RecrutandoFase 3

Idades de 18 a 50 · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT06748222

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Medical University of South Carolina, Charleston

RecrutandoFase 2

Idades de 18 a 55 · Mulheres · Atualizado em 27 de jul. de 2026 · NCT06184750

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Prisma Health - Upstate (ITOR)_Edenfield ( Site 0053), Greenville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06686394

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Medical University of South Carolina, Charleston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de abr. de 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Medical University of South Carolina, Charleston
McLeod Regional Medical Center, Florence
e mais 5

RecrutandoFase 3

Idades de 50 a 70 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

AnMed Health Cancer Center, Anderson
Beaufort Memorial Hospital, Beaufort
Saint Joseph's/Candler - Bluffton Campus, Bluffton
e mais 18

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Spartanburg Medical Center, Spartanburg

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT06401421

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Medical University of South Carolina, Charleston
McLeod Health, Florence

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Greenville

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Prisma Health Cancer Institute - Butternut, Greenville
Prisma Health Cancer Institute - Faris, Greenville
Prisma Health Cancer Institute - Eastside, Greenville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT03418961

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Roper St. Francis Physician Partners - Breast Surgery, Charleston
Tidelands Health Coastal Carolina Breast Center, Georgetown

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2025 · NCT03053193

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

Prisma Health Cancer Institute, Greenville

RecrutandoEstudo observacional

Idades 20 e acima · Mulheres · Atualizado em 4 de nov. de 2024 · NCT06672497

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.